Fenofibrate USP

Composition : Fenofibrate USP 145 mg Tablet.

Indication : Fenofibrate is indicated as an adjunctive therapy to diet for the treatment of adults with hypertriglyceridemia (Types IV and V hyperlipidemia). Fenofibrate is also indicated in hypercholesterolemia or, mixed Dislipidemia (type II hyperlipidemia).

Dosage and administration : For the treatment of adult patients with hypercholesterolemia or mixed hyperlipidemia, the initial dose of Fenatrol is 200 mg per day. For adult patients with hypertriglyceridemia, the initial dose is 67 to 200 mg per day. Dose should be individualized according to patient response. Fenatrol should be given with meal there by, optimizing the bioavailability of the medication. Or, as directed by the registered physician.

Packing :

Fenatrol-145 : 3 x 10's Tablet in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2020 Designed and Developed by ATI Limited.